These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 30092671)
1. Progress on norovirus vaccine research: public health considerations and future directions. Mattison CP; Cardemil CV; Hall AJ Expert Rev Vaccines; 2018 Sep; 17(9):773-784. PubMed ID: 30092671 [TBL] [Abstract][Full Text] [Related]
2. Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial. Lindesmith LC; Ferris MT; Mullan CW; Ferreira J; Debbink K; Swanstrom J; Richardson C; Goodwin RR; Baehner F; Mendelman PM; Bargatze RF; Baric RS PLoS Med; 2015 Mar; 12(3):e1001807. PubMed ID: 25803642 [TBL] [Abstract][Full Text] [Related]
3. Recent advances in human norovirus research and implications for candidate vaccines. Cates JE; Vinjé J; Parashar U; Hall AJ Expert Rev Vaccines; 2020 Jun; 19(6):539-548. PubMed ID: 32500763 [TBL] [Abstract][Full Text] [Related]
5. Norovirus Vaccine: Priorities for Future Research and Development. Esposito S; Principi N Front Immunol; 2020; 11():1383. PubMed ID: 32733458 [TBL] [Abstract][Full Text] [Related]
6. New insights into the global burden of noroviruses and opportunities for prevention. Hall AJ; Glass RI; Parashar UD Expert Rev Vaccines; 2016 Aug; 15(8):949-51. PubMed ID: 27142965 [No Abstract] [Full Text] [Related]
7. Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs. Kocher J; Bui T; Giri-Rachman E; Wen K; Li G; Yang X; Liu F; Tan M; Xia M; Zhong W; Jiang X; Yuan L J Virol; 2014 Sep; 88(17):9728-43. PubMed ID: 24920797 [TBL] [Abstract][Full Text] [Related]
8. Progress toward norovirus vaccines: considerations for further development and implementation in potential target populations. Aliabadi N; Lopman BA; Parashar UD; Hall AJ Expert Rev Vaccines; 2015; 14(9):1241-53. PubMed ID: 26224658 [TBL] [Abstract][Full Text] [Related]
9. The Vast and Varied Global Burden of Norovirus: Prospects for Prevention and Control. Lopman BA; Steele D; Kirkwood CD; Parashar UD PLoS Med; 2016 Apr; 13(4):e1001999. PubMed ID: 27115709 [TBL] [Abstract][Full Text] [Related]
11. Noroviruses: epidemiology, immunity and prospects for prevention. Pringle K; Lopman B; Vega E; Vinje J; Parashar UD; Hall AJ Future Microbiol; 2015; 10(1):53-67. PubMed ID: 25598337 [TBL] [Abstract][Full Text] [Related]
12. Functionality and avidity of norovirus-specific antibodies and T cells induced by GII.4 virus-like particles alone or co-administered with different genotypes. Malm M; Tamminen K; Heinimäki S; Vesikari T; Blazevic V Vaccine; 2018 Jan; 36(4):484-490. PubMed ID: 29246474 [TBL] [Abstract][Full Text] [Related]